Increasing Incidence Of Cancer Fueling The Growth Of The Market Due To Rising Demand For Early And Personalized Diagnosis Is Supporting Development Across The Somatic Genetic Testing Market

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Are The Forecasted Market Size Figures For The Somatic Genetic Testing Market In 2026 And 2030?

The market size for somatic genetic testing has seen rapid expansion in recent years. It is projected to increase from $7.78 billion in 2025 to $8.88 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 14.1%. Historically, this growth can be attributed to various factors such as restricted access to genetic testing, a dependence on conventional diagnostic techniques, growing awareness of somatic mutations in cancer, the expansion of hospital and clinical laboratory infrastructure, and rising investment in research institutes.

The somatic genetic testing market is anticipated to experience substantial growth in the coming years, with projections indicating its size will reach $14.92 billion in 2030, at a compound annual growth rate (CAGR) of 13.9%. This expansion during the forecast period is primarily driven by advancements in next-generation sequencing (NGS) and multi-omics technologies, the widening availability of at-home and clinical sequencing services, an increase in precision medicine initiatives, rising government funding for genetic testing programs, and the integration of AI-based analytics for interpreting mutations. Key trends expected over the forecast horizon include the growing adoption of targeted gene panels for cancer and rare diseases, increased utilization of next-generation sequencing (NGS) technologies, the evolution of personalized and precision oncology treatments, the proliferation of at-home genetic testing solutions, and the incorporation of multi-omics data for clinical decision-making.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

What Major Growth Factors Are Impacting The Somatic Genetic Testing Market?

The escalating occurrence of cancer is projected to stimulate the expansion of the somatic genetic testing market in the future. Cancer encompasses a category of illnesses marked by the unregulated proliferation and dissemination of atypical cells within the body. This growing burden of cancer is attributed to various lifestyle factors, including unhealthy dietary habits, tobacco use, sedentary lifestyles, and heavy alcohol intake. Somatic genetic testing assists in identifying cancer by pinpointing genetic mutations specific to tumors, thereby facilitating precise and individualized treatment strategies. Furthermore, it reduces the need for invasive methods through the application of advanced technologies, enhancing diagnostic precision and improving results for patients. As an illustration, data from November 2023 by the Canadian Cancer Society, a national cancer agency based in Canada, indicated that in 2023, an estimated 239,100 Canadians are anticipated to receive a cancer diagnosis, with approximately 86,700 expected to succumb to the illness. Consequently, the rising occurrence of cancer serves as a significant impetus for the growth of the somatic genetic testing market.

How Is The Somatic Genetic Testing Market Distributed Across Key Segments?

The somatic genetic testing market covered in this report is segmented –

1) By Type: Targeted Gene Panels, Whole Exome Sequencing, Whole Genome Sequencing, Other Testing Methods

2) By Sample: Tissue-Based, Blood-Based, Bone Marrow Aspirates, Other Samples

3) By Technology: Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS), Microarray, Sanger Sequencing, Other Technologies

4) By Application: Cancer Diagnosis, Cardiovascular Disorders, Neurological Disorders, Other Applications

5) By End-User: Hospitals, Clinical Laboratories, Research Institutes, Other End-Users

Subsegments:

1) By Targeted Gene Panels: Oncology Panels, Neurology Panels, Cardiovascular Panels, Rare Disease Panels, Pharmacogenomics Panels

2) By Whole Exome Sequencing: Diagnostic Whole Exome Sequencing, Clinical Research Whole Exome Sequencing, Population-Based Whole Exome Sequencing

3) By Whole Genome Sequencing: Clinical Whole Genome Sequencing, Research Whole Genome Sequencing, De Novo Whole Genome Sequencing, Cancer Whole Genome Sequencing

4) By Other Testing Methods: Copy Number Variation Testing, Mitochondrial Deoxyribonucleic Acid (DNA) Testing, Ribonucleic Acid (RNA) Sequencing, Epigenetic Testing

Which Trends Are Influencing The Expansion Of The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are concentrating on developing advanced diagnostic solutions, such as liquid biopsy tests, to enhance accuracy, enable early detection, and decrease the necessity for invasive procedures. Liquid biopsy tests refer to non-invasive methods that analyze circulating tumor DNA (ctDNA) or other biomarkers in blood samples to detect cancer-related genetic mutations. For instance, in September 2024, Strand Life Sciences, an India-based genomics and bioinformatics company, launched the Somatic Advantage 74 Liquid Biopsy (SA74 LB) test, a next-generation liquid biopsy test designed to detect circulating tumor DNA (ctDNA) from blood samples. The SA74-LB is a comprehensive next-generation sequencing (NGS)-based test designed to detect somatic mutations across 74 key cancer-related genes. This test aids in personalized cancer treatment by identifying actionable mutations, monitoring treatment response, and detecting minimal residual disease (MRD) without the need for traditional tissue biopsies. It supports precision oncology, helping guide targeted therapies and monitor disease progression or resistance in real-time.

Who Are The Prominent Players Across The Somatic Genetic Testing Market?

Major companies operating in the somatic genetic testing market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Agilent Technologies Inc., Illumina Inc., QIAGEN N.V., Exact Sciences Corp., ARUP Laboratories Inc., Natera Inc., Myriad Genetics Inc., Fulgent Genetics Inc., Invitae Corporation, NeoGenomics Laboratories Inc., Guardant Health Inc., MedGenome Labs Ltd., Caris Life Sciences Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California Inc., Invivoscribe Inc., Centogene N.V., Circulogene Theranostics LLC.

Access The Complete Somatic Genetic Testing Market Report:

https://www.thebusinessresearchcompany.com/report/somatic-genetic-testing-global-market-report

Which Region Accounts For The Highest Share Of The Somatic Genetic Testing Market?

North America was the largest region in the somatic genetic testing market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the somatic genetic testing market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Somatic Genetic Testing Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=27421&type=smp

Browse Through More Reports Similar to the Global Somatic Genetic Testing Market 2026, By The Business Research Company

Smart Workplace Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-workplace-global-market-report

Office Automation Market Report 2026

https://www.thebusinessresearchcompany.com/report/office-automation-global-market-report

Smart Windows Market Report 2026

https://www.thebusinessresearchcompany.com/report/smart-windows-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795